Presentation is loading. Please wait.

Presentation is loading. Please wait.

The natural progression of peanut allergy: Resolution and the possibility of recurrence  David M. Fleischer, MDa, Mary Kay Conover-Walker, MSN, RN, CRNPa,

Published byAlexandra Carvalho Modified over 5 years ago

Similar presentations

Presentation on theme: "The natural progression of peanut allergy: Resolution and the possibility of recurrence  David M. Fleischer, MDa, Mary Kay Conover-Walker, MSN, RN, CRNPa,"— Presentation transcript:

1 The natural progression of peanut allergy: Resolution and the possibility of recurrence 
David M. Fleischer, MDa, Mary Kay Conover-Walker, MSN, RN, CRNPa, Lynn Christie, MS, RD, LDb, A.Wesley Burks, MDb, Robert A. Wood, MDa  Journal of Allergy and Clinical Immunology  Volume 112, Issue 1, Pages (July 2003) DOI: /mai Copyright © 2003 Mosby, Inc. Terms and Conditions

2 Fig. 1 PN-IgE levels at challenge in patients who passed challenges (n = 44; range, < 0.35 to 4.9 kUA/L; median, < 0.35 kUA/L) and failed challenges (n = 36; range, < 0.35 to 5 kUA/L; median, 1.85 kUA/L). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

3 Fig. 2 Initial PN-IgE levels at diagnosis in patients who passed challenges (n = 21; range, < 0.35 to 82.2 kUA/L; median, 1.1 kUA/L) and failed challenges (n = 13; range, < 0.35 to 23.9 kUA/L; median, 3.0 kUA/L). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

Download ppt "The natural progression of peanut allergy: Resolution and the possibility of recurrence  David M. Fleischer, MDa, Mary Kay Conover-Walker, MSN, RN, CRNPa,"

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Kiwi fruit allergy: A new birch pollen–associated food allergy

Kiwi fruit allergy: A new birch pollen–associated food allergy
Advances in Diagnosing Peanut Allergy

Advances in Diagnosing Peanut Allergy
Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.

Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.
Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo- controlled multicenter trial  David M. Fleischer, MD, A. Wesley Burks,

Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo- controlled multicenter trial  David M. Fleischer, MD, A. Wesley Burks,
The Natural History of Food Allergy

The Natural History of Food Allergy
Kiwi fruit allergy: A new birch pollen–associated food allergy

Kiwi fruit allergy: A new birch pollen–associated food allergy
Laboratory animal allergy

Laboratory animal allergy
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Rosa Codina, PhD, Richard F. Lockey, MD 

Rosa Codina, PhD, Richard F. Lockey, MD 
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Fuad M. Baroody, MD, Se-Hoon Suh, MD, Robert M. Naclerio, MD 

Fuad M. Baroody, MD, Se-Hoon Suh, MD, Robert M. Naclerio, MD 
Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass?  Song Wan, MD, PhDa, Jean-Louis LeClerc, MDb, Chi-Hoang Huynh,

Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass?  Song Wan, MD, PhDa, Jean-Louis LeClerc, MDb, Chi-Hoang Huynh,
Practice Notes from the AAAI

Practice Notes from the AAAI
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia  Carol K. Fosso, MDa,

Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia  Carol K. Fosso, MDa,
Product characteristics and pharmacokinetics of intranasal ipratropium bromide  Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.

Product characteristics and pharmacokinetics of intranasal ipratropium bromide  Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.

Similar presentations

Ads by Google